11 employees
Biorasis commercializes wireless, needle implantable, miniaturized sensor platforms for real-time glucose monitoring.
2007
$3M
from 1 investors over 1 rounds
Biorasis Inc. raised $3M on December 5, 2018
Investors: The Leona M and Harry B Helmsley Charitable Trust